Displaying 61 - 80 of 174
FTC, Georgia Attorney General Sue Stem Cell Institute of America Co-Founders for Deceptive Joint Pain Cure-All Marketing Scheme
Physician's Technology, LLC
In June 2020, the marketers of a low-level light therapy device (LLLT) called Willow Curve agreed to stop making allegedly deceptive claims that the device treats chronic, severe pain and associated inflammation, under a settlement with the FTC.
In a complaint filed in federal court the FTC alleged that the marketers of Willow Curve promoted the device nationwide since 2014, touting it as a “smart†device that is “clinically proven,†even though they lack scientific evidence to support these claims. The order settling the complaint also requires two defendants to pay $200,000 each to the Commission. In August 2021, the FTC sent refunds totaling more than $350,000 to defrauded consumers.
FTC Approves Final Administrative Consent Order against Kushly Industries LLC and its Owner for Making Unsupported Health Claims for CBD Products
FTC Approves Final Administrative Consent Orders against Companies that Deceptively Marketed Fish Oil Supplements with False Claims They Were Clinically Proven to Treat Liver Disease
Kushly Industries LLC; Analysis of Proposed Consent Order To Aid Public Comment
Quickwork LLC and Eric A. Nepute
In April 2021, the FTC charged St. Louis-based chiropractor Eric Anthony Nepute and his company Quickwork LLC with violating the COVID-19 Consumer Protection Act and the Â鶹´«Ã½ Trade Commission Act, by deceptively marketing products containing vitamin D and zinc as scientifically proven to treat or prevent COVID-19. This is the first such case in which the agency has sought civil penalties.
The FTC Directed 30 More Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Prevent or Treat COVID-19
Opening Statement Of Acting Chairwoman Rebecca Kelly Slaughter before the United States House Committee on Energy and Commerce Subcommittee on Consumer Protection and Commerce: The Urgent Need To Fix Section 13(B) Of The FTC Act
FTC Testifies before Congress on its Work to Curb COVID-19 Scams and Warn Consumers about Pandemic-related Frauds, Cons, and Swindles
Prepared Statement of the Â鶹´«Ã½ Trade Commission: The Urgent Need to Fix Section 13(b) of the FTC Act
Prepared Statement of the Â鶹´«Ã½ Trade Commission: Curbing COVID Cons: Warning Consumers about Pandemic Frauds, Scams, and Swindles
Prepared Statement of Acting Chairwoman Rebecca Kelly Slaughter: Strengthening the Â鶹´«Ã½ Trade Commission's Authority to Protect Consumers
Prepared Statement of Commissioner Christine S. Wilson: Strengthening the Â鶹´«Ã½ Trade Commission's Authority to Protect Consumers
Prepared Statement of Commissioner Noah Joshua Phillips: Strengthening the Â鶹´«Ã½ Trade Commission's Authority to Protect Consumers
Prepared Statement of Commissioner Rohit Chopra: Strengthening the Â鶹´«Ã½ Trade Commission's Authority to Protect Consumers
Protecting Consumers During the COVID-19 Pandemic: A Year in Review
One Year into COVID-19 Pandemic, New FTC Staff Report Highlights Agency’s Ongoing Efforts to Protect Consumers
BASF SE and DIEM Labs; Analysis of Proposed Consent Orders To Aid Public Comment
Displaying 61 - 80 of 174